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 Introduction
Neonicotinoids is a relatively novel group of insecticides. 
This group of insecticides acts by exerting an agonistic effect 
on postsynaptic nicotinic receptors and are considered to 
have a low toxicity profile for humans. Nevertheless, with the 
recent increase in their use, reports of poisonings with these 
agents have dramatically increased and even some fatalities 
have been reported (1). 
The neonicotinoid group of insecticides has 7 members: 
acetamiprid, clothianidin, dinotefuran, imidacloprid, 
nitenpyram, thiacloprid, and thiamethoxam. Among these, 
acetamiprid has increasingly been used in large scale against 
sucking insects. In rats, its median lethal dose after oral 
intake is 140-417 mg/kg. Although there are many reports of 
poisonings with imidacloprid, our search revealed no reports 
of poisoning with acetamiprid in the English literature, except 
for a report of 2 cases (2). Therefore, the clinical outcomes 
of acetamiprid poisoning after acute oral intake are yet to be 
clearly defined. 
Case Report
A 41-year-old woman with a history of epilepsy but no 
seizure episodes on valproic acid for the last 5 years was 
admitted to hospital after suicidal oral intake of 40 g (2 
table spoons) Goldplan SP (Agrobest-Turkey), an insecticide 
in the effervescent form containing 20% acetamiprid. 
On admission, she was conscious with full cooperation 
and orientation; her pupils were 4 mm in diameter and 
isochoric, and light reflexes were bilateral intact. However, 
she had nausea, vomiting, and abdominal pain, and she 
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was tachycardic and hypertensive. She was admitted to 
the intensive care unit. Her admission and follow-up vital 
signs, arterial blood gas analyses, and laboratory tests 
were listed on Table 1. At 32nd hour of intensive care unit 
admission she developed altered consciousness, aphasia, 
and muscle weakness characterized by complete loss of 
movement, particularly affecting proximal muscle groups 
of upper and lower extremities. Considering that she 
may have sustained an acute intracranial pathology, she 
was examined with a cranial brain tomography, magnetic 
resonance imaging (MRI) and diffusion MRI examinations, 
but no pathology was revealed by these examinations. Her 
spontaneous respiration was sufficient under supplemental 
oxygen therapy at 2 L/min. A repeat brain MRI examination 
on 5th day of admission showed subtle hyperintensities in 
bilateral superior frontal gyri, subcortical white matter, and 
periventricular white matter. An electroencephalogram 
revealed an epileptic activity of focal origin due to focal sharp 
and slow wave activities concentrated in the right parietal 
region, which were compatible with her past history of 
epilepsy. A cerebrospinal fluid (CSF) sample culture ruled out 
meningitis. The patient’s muscle weakness persisted in all 
extremities and neck muscles, and she was communicated 
only by eye movements. Bedside physiotherapy was started. 
She began oral intake on 9th day of admission, had significant 
improvement in verbal responses by 10th day, began 
unassisted walking on 17th day, and was discharged without 
any sequela on 22nd day. At regular telephone follow-ups she 
was mentally and physically healthy.
Discussion
Neonicotinoids lead to the death of insects by 
causing neuromuscular paralysis as a result of excessive 
depolarization due to their potent agonistic effects particularly 
on the α2β4 subunits of nicotinic acetylcholine receptors. 
Their affinity for nicotinic receptors is low in mammals and 
they hardly pass blood brain barrier (3). Still, depending on the 
amount taken, they can lead to nausea, vomiting, abdominal 
pain, tachycardia, respiratory failure, aspiration pneumonia, 
agitation, confusion, coma, muscle weakness in humans. 
They are associated with lower mortality (2.9%) than other 
insecticides, namely organophophates (12.3%), carbamates 
(7.3%), pyrethrins and pyrethroids (3.1%) (4). Severe side 
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Table 1. Clinical data on hospital stay
1st day 3rd day 5th day 10th day 15th day 22nd day
Blood pressure (mmHg) 146/95 135/85  124/68 128/85 112/67 112/65
Pulse rate (per min) 82 89 74 92 94 78
SpO2 (%) 98 97 98 96 95 96
Temperature (°C) 36.2 35.8 36.1 36.4 36.4 35.9
Ph 7.66 7.44 7.43 7.47 7.48 -
PaCO2 (mmHg) 11 36.7 36.4 36.8 28.3 -
PaO2 (mmHg) 125 104 168 91.1 81.1 -
BE (mmol/L) -5.3 +0.7 +0.1 3.2 -1.7 -
HCO3 (mmol/L) 20.1 24.2 23.8 26.7 21.2 -
Na (mmol/L) 135 137 136 139 144 134
K (mmol/L) 4 3.68 3.5 3.7 4.1 3.6
Cl (mmol/L) 111 108 105 109 109 101
BUN (mg/dL) 29 14 12 16 24 14
Creatinine (mg/dL) 0.68 0.63 0.55 0.56 0.75 0.56
AST (U/L) 27 16 16 25 63 34
ALT (U/L) 16 10 20 56 101 161
CK (U/L) 78 65 - - 61 -
Hb (g/dL) 14.4 12.3 12.2 12.6 12.5 12.2
Leukocyte (per mm3) 8800 7300 5200 11700 8400 4300
BUN: Blood urea nitrogen, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, CK: Creatine kinase, Hb: Hemoglobin
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effects and death occurs after suicidal or accidental oral 
intake rather than inhalation or dermal exposure (2).
Muscle weakness has been frequently reported in 
poisonings with acetamiprid and other neonicotinoids. 
However, apart from fatal cases in which severe respiratory 
failure accompanies clinical picture, muscle weakness has 
generally been reported to recover within hours. An interesting 
point in our case was muscle weakness particularly affecting 
proximal muscle groups, which we also held responsible for 
aphasia in our patient, that was absent on presentation but 
developed 32 hours after intensive care unit admission. 
This clinical presentation calls into mind the intermediate 
syndrome frequently encountered in organophosphate 
poisonings. As is well known, the intermediate syndrome 
is a clinical condition that develops within 24-96 hours after 
organophosphate intake in 20% of victims. Its characteristic 
signs include cranial nerve involvement, respiratory failure, 
weakness and loss of deep tendon reflexes in neck and 
proximal extremity muscles. Possible mechanisms include 
prolonged acetylcholinesterase inhibition, downregulation or 
desensitization of acetylcholine receptors, muscle necrosis, 
oxidative injury-associated myopathy, and inadequate 
oxime treatment. Complete recovery can be achieved with 
appropriate treatment including respiratory support within 5 
to 18 days (5,6). 
Also in the present case the time of onset and duration 
of symptoms suggest the intermediate syndrome. 
However, no such a presentation has ever been reported 
with neonicotinoid poisoning. It is difficult to predict what 
caused the clinical presentation of the patient that we 
are familiar with organophosphate poisonings. It can be 
assumed that the above mentioned mechanisms are also 
valid for this patient. 
The treatment of acute poisoning with neonicotinoids 
consists of symptomatic and supportive treatment. 
Respiratory support was not necessary in this patient. Early 
physiotherapy was started during the period of muscle 
weakness, and nutritional support was provided via parenteral 
route to avoid the risk of aspiration pneumonia. On the other 
hand, the outcomes with medications like atropine and 
oximes are unclear in the setting of neonicotinoid poisoning 
(1).
In conclusion, symptomatic and supportive treatment 
sufficed in the management of an intermediate syndrome-
like clinical presentation encountered for the first time in a 
setting of neonicotinoid insecticide poisoning. Large case 
series or animal studies may be needed to study the role of 
oxime group of medications to prevent the development of 
an intermediate syndrome-like clinical course.
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